| 1 |
Jirón M，Pate V，Hanson LC，et al．Trends in Prevalence and Determinants of Potentially Inappropriate Prescribing in the United States: 2007 to 2012[J]．J Am Geriatr Soc，2016，64（4）：788-797．
|
| 2 |
Johnell K，Klarin I．The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register[J]．Drug Saf，2007，30（10）：911-918．
|
| 3 |
Nanji KC，Patel A，Shaikh S，et al．Evaluation of Perioperative Medication Errors and Adverse Drug Events[J]．Anesthesiology，2016，124（1）：25-34．
|
| 4 |
Kristensen SD，Knuuti J，Saraste A，et al．2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)[J]．Eur Heart J，2014，35（35）：2383-2431．
|
| 5 |
Sakai T，Aokage K，Katsumata S，et al．Continuation of aspirin perioperatively for lung resection: a propensity matched analysis[J]．Surg Today，2021，51（6）：1054-1060．
|
| 6 |
Stamenovic D，Schneider T，Messerschmidt A．Aspirin for patients undergoing major lung resections: hazardous or harmless?†[J]．Interact Cardiovasc Thorac Surg，2019，28（4）：535-541．
|
| 7 |
Yu WS，Jung HS，Lee JG，et al．Safety of thoracoscopic surgery for lung cancer without interruption of anti-platelet agents[J]．J Thorac Dis，2015，7（11）：2024-2032．
|
| 8 |
Fleisher LA，Fleischmann KE，Auerbach AD，et al．2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]．Circulation，2014，130（24）：e278-e333．
|
| 9 |
Chassot PG，Delabays A，Spahn DR．Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction[J]．Br J Anaesth，2007，99（3）：316-328．
|
| 10 |
Patel PA，Fleisher LA．Aspirin, clopidogrel, and the surgeon[J]．Adv Surg，2014，48：211-222．
|
| 11 |
Devereaux PJ，Mrkobrada M，Sessler DI，et al．Aspirin in patients undergoing noncardiac surgery[J]．N Engl J Med，2014，370（16）：1494-1503．
|
| 12 |
Wolff G，Navarese EP，Brockmeyer M，et al．Perioperative aspirin therapy in non-cardiac surgery: A systematic review and meta-analysis of randomized controlled trials[J]．Int J Cardiol，2018，258：59-67．
|
| 13 |
Burger W，Chemnitius JM，Kneissl GD，et al．Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis[J]．J Intern Med，2005，257（5）：399-414．
|
| 14 |
Ferraris VA，Saha SP，Oestreich JH，et al．2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations[J]．Ann Thorac Surg，2012，94（5）：1761-1781．
|
| 15 |
Mahla E，Tantry US，Schoerghuber M，et al．Platelet Function Testing in Patients on Antiplatelet Therapy before Cardiac Surgery[J]．Anesthesiology，2020，133（6）：1263-1276．
|
| 16 |
Baron TH，Kamath PS，McBane RD．Management of antithrombotic therapy in patients undergoing invasive procedures[J]．N Engl J Med，2013，368（22）：2113-2124．
|
| 17 |
Douketis JD，Spyropoulos AC，Kaatz S，et al．Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation[J]．N Engl J Med，2015，373（9）：823-833．
|
| 18 |
January CT，Wann LS，Calkins H，et al．2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons[J]．Circulation，2019，140（2）：e125-e151．
|
| 19 |
围术期出凝血管理麻醉专家共识协作组．围术期出凝血管理麻醉专家共识[J]．中华麻醉学杂志，2020，40（9）：1042-1053．
|
| 20 |
Jaffer AK，Brotman DJ，Chukwumerije N．When patients on warfarin need surgery[J]．Cleve Clin J Med，2003，70（11）：973-984．
|
| 21 |
Schulman S，Elbazi R，Zondag M，et al．Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study[J]．Thromb J，2008，6：15．
|
| 22 |
Douketis JD，Spyropoulos AC，Duncan J，et al．Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant[J]．JAMA Intern Med，2019，179（11）：1469-1478．
|
| 23 |
Raval AN，Cigarroa JE，Chung MK，et al．Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association[J]．Circulation，2017，135（10）：e604-e633．
|
| 24 |
Roshanov PS，Rochwerg B，Patel A，et al．Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort[J]．Anesthesiology，2017，126（1）：16-27．
|
| 25 |
Howell SJ．Consensus statements and expert guidance: interpret with care[J]．Br J Anaesth，2019，122（6）：719-722．
|
| 26 |
Ziegler CH，Lovette JB．Operative complications after therapy with reserpine and reserpine compounds[J]．JAMA，1961，176：916-919．
|
| 27 |
Munson WM，Jenicek JA．Effect of anesthetic agents on patients receiving reserpine therapy[J]．Anesthesiology，1962，23：741-746．
|
| 28 |
Irizarry-Alvarado JM．Perioperative Management of Beta Blockers and Other Antiarrhythmic Medications[J]．Curr Clin Pharmacol，2017，12（3）：141-144．
|
| 29 |
Lazar HL，McDonnell M，Chipkin SR，et al．The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery[J]．Ann Thorac Surg，2009，87（2）：663-669．
|
| 30 |
American Diabetes Association Professional Practice Committee；Draznin B，Aroda VR，et al．9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022[J]．Diabetes Care，2022，45（Suppl 1）：S125-S143．
|
| 31 |
Duggan EW，Carlson K，Umpierrez GE．Perioperative Hyperglycemia Management: An Update[J]．Anesthesiology，2017，126（3）：547-560．
|
| 32 |
Preiser JC，Provenzano B，Mongkolpun W，et al．Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes[J]．Anesthesiology，2020，133（2）：430-438．
|
| 33 |
Thiruvenkatarajan V，Jesudason D，Nanjappa N，et al．Perioperative Management of Glucose-lowering Drugs: Comment[J]．Anesthesiology，2021，134（2）：349-350．
|
| 34 |
Cheisson G，Jacqueminet S，Cosson E，et al．Perioperative management of adult diabetic patients. Review of hyperglycaemia: definitions and pathophysiology[J]．Anaesth Crit Care Pain Med，2018，37 Suppl 1：S5-S8．
|
| 35 |
Membership of the Working Party；Barker P，Creasey PE，et al．Peri-operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland[J]．Anaesthesia，2015，70（12）：1427-1440．
|
| 36 |
Hulst AH，Polderman JAW，Siegelaar SE，et al．Preoperative considerations of new long-acting glucagon-like peptide-1 receptor agonists in diabetes mellitus[J]．Br J Anaesth，2021，126（3）：567-571．
|
| 37 |
Pfeifer KJ，Selzer A，Whinney CM，et al．Preoperative Management of Gastrointestinal and Pulmonary Medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement[J]．Mayo Clin Proc，2021，96（12）：3158-3177．
|
| 38 |
Renew JR，Aniskevich S．Perioperative Pulmonary Medication Management[J]．Curr Clin Pharmacol，2017，12（3）：182-187．
|
| 39 |
Oprea AD，Keshock MC，O'Glasser AY，et al．Preoperative Management of Medications for Psychiatric Diseases: Society for Perioperative Assessment and Quality Improvement Consensus Statement[J]．Mayo Clin Proc，2022，97（2）：397-416．
|
| 40 |
Zafirova Z，Vázquez-Narváez KG，Borunda D．Preoperative Management of Medications[J]．Anesthesiol Clin，2018，36（4）：663-675．
|
| 41 |
Jamal BT，Herb K．Perioperative management of patients with myasthenia gravis: prevention, recognition, and treatment[J]．Oral Surg Oral Med Oral Pathol Oral Radiol Endod，2009，107（5）：612-615．
|
| 42 |
Liu MM，Reidy AB，Saatee S，et al．Perioperative Steroid Management: Approaches Based on Current Evidence[J]．Anesthesiology，2017，127（1）：166-172．
|
| 43 |
徐建国，唐会，姚尚龙，等．肾上腺糖皮质激素围手术期应用专家共识(2017版)[J]．临床麻醉学杂志，2017，33（7）：712-716．
|
| 44 |
Farmakidis C，Pasnoor M，Dimachkie MM，et al．Treatment of Myasthenia Gravis[J]．Neurol Clin，2018，36（2）：311-337．
|
| 45 |
Vinogradova Y，Coupland C，Hippisley-Cox J．Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases[J]．BMJ，2019，364：k4810．
|
| 46 |
Pfeifer KJ，Selzer A，Mendez CE，et al．Preoperative Management of Endocrine, Hormonal, and Urologic Medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement[J]．Mayo Clin Proc，2021，96（6）：1655-1669．
|
| 47 |
Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures: An Updated Report by the American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration[J]．Anesthesiology，2017，126（3）：376-393．
|
| 48 |
Dobson G，Chong M，Chow L，et al．Guidelines to the Practice of Anesthesia - Revised Edition 2018[J]．Can J Anaesth，2018，65（1）：76-104．
|
| 49 |
Smith I，Kranke P，Murat I，et al．Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology[J]．Eur J Anaesthesiol，2011，28（8）：556-569．
|